Objective To study the risk factors of postoperative hypocalcemia after resection of thyroid nodules. Methods A retrospective study was conducted on 124 patients undergoing thyroid nodule resection surgery, including age, gender, mass nature, lesion location （unilateral/bilateral）, lymph node dissection, surgical approach, perioperative blood calcium （adjusted and un-adjusted）, parathyroid hormone （PTH）, and blood magnesium. Patients were divided into a hypocalcemia group and a non-hypocalcemia group based on their postoperative blood calcium levels, to compare the differences between the two groups and thereby investigate the risk factors for hypocalcemia after thyroid nodule resection. Results Of the 124 cases enrolled, 12 cases （9.7%） developed hypocalcemia after the operation, with an average blood calcium of （2.10±0.08） mmol/L. After albumin correction of blood calcium level, 9 cases （7.3%） had hypocalcemia, with an average blood calcium of （2.05±0.14） mmol/L. There were no statistically significant differences between the two groups stratified by corrected blood calcium levels in terms of age, gender, mass nature, and performance of lymph node dissection （P> 0.05）. However, significant differences were observed in lesion location （unilateral/bilateral）, surgical approach, average postoperative PTH level, and presence of postoperative hypomagnesemia （P<0.05）. Conclusion For patients with postoperative hypoproteinemia, corrected blood calcium levels should be used to evaluate whether the patient needs additional calcium supplementation. Surgical procedure is a high-risk factor for postoperative hypocalcemia, and postoperative hypomagnesemia and postoperative PTH reduction are associated with hypocalcemia.
HUO Jianting
,
HUO Huanmin
,
DING Min
,
XIE Rongli
,
SHEN Dongjie
,
FEI Jian
. Risk factors for hypocalcemia after thyroid nodule resection[J]. Surgical Research and New Technique, 2025
, 14(3)
: 211
-215
.
DOI: 10.3969/j.issn.2095-378X.2025.03.003
[1] Cabanillas ME, McFadden DG, Durante C. Thyroid cancer[J].Lancet,2016,388(10061):2783-2795.
[2] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[3] Sebastian M, Rudnicki J, Jakubaszko W, et al.Clinical and biochemical factors affecting postoperative hypocalcemia after near-total thyroidectomy[J]. Adv Clin Exp Med,2013,22(5):675-682.
[4] Demeester-Mirkine N, Hooghe L, Geertruyden JV, et al.Hypocalcemia after thyroidectomy[J]. Arch Surg,1992,127(7):854-858.
[5] Wang TS, Cheung K, Roman SA, et al.To supplement or not to supplement:a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy[J]. Ann Surg Oncol,2011,18(5):1293-1299.
[6] Gouri A, Dekaken A.A comparison of corrected serum calcium levels to ionized calcium levels in haemodialysis patients[J].Ann Biol Clin,2012,70(2):210-212.
[7] Bushinsky DA, Monk RD.Calcium[J]. Lancet,1998,352(9124):306-311.
[8] Smith JD, Wilson S, Schneider HG.Misclassification of calcium status based on albumin-adjusted calcium:studies in a tertiary hospital setting[J]. Clin Chem,2018,64(12):1713-1722.
[9] Grodski S, Serpell J.Evidence for the role of perioperative PTH measurement after total thyroidectomy as a predictor of hypocalcemia[J]. World J Surg,2008,32(7):1367-1373.
[10] Wilson RB, Erskine C, Crowe PJ.Hypomagnesemia and hypocalcemia after thyroidectomy:prospective study[J]. World J Surg,2000,24(6):722-726.
[11] Chincholikar SP, Ambiger S.Association of hypomagnesemia with hypocalcemia after thyroidectomy[J]. Indian J Endocrinol Metabolism,2018,22(5):656-660.
[12] Sousa Ade A, Salles JM, Soares JM, et al.Evolution of blood magnesium and phosphorus ion levels following thyroidectomy and correlation with total calcium values[J]. Sao Paulo Med J,2010,128(5):268-271.
[13] Sabour S, Manders E, Steward DL.The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia[J]. Otolaryngol Head Neck Surg,2009,141(6):727-729.
[14] Brandi ML, Bilezikian JP, Shoback D, et al.Management of hypoparathyroidism:summary statement and guidelines[J]. J Clin Endocrinol Metabolism,2016,101(6):2273-2283.
[15] Heaney RP, Dowell MS, Bierman J, et al.Absorbability and cost effectiveness in calcium supplementation[J]. J Am Coll Nutr,2001,20(3):239-246.
[16] Russell RG, Smith R, Walton RJ, et al.1,25-dihydroxy cholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism[J]. Lancet,1974,2(7871):14-17.
